{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:45:54Z","timestamp":1777103154809,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ajp.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T13:29:59Z","timestamp":1518701399000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Current status of vaccines in psychiatry\u2014A narrative review"],"prefix":"10.1016","volume":"31","author":[{"given":"Pooja Patnaik","family":"Kuppili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshini","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2018.02.004_bib0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3923\/jpt.2009.30.35","article-title":"Immunotherapy of 347 volunteer outpatient morphine addicts by human therapeutic morphine vaccine in Kermanshah province of Iran","volume":"4","author":"Akbarzadeh","year":"2009","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.vaccine.2014.07.085","article-title":"Adjuvants for vaccines to drugs of abuse and addiction","volume":"32","author":"Alving","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ajp.2018.02.004_bib0015","unstructured":"Confirmed cases of measles, mumps and rubella in England and Wales: 1996 to 2016 \u2212 GOV.UK [WWW Document], 2014. URL https:\/\/www.gov.uk\/government\/publications\/measles-confirmed-cases\/confirmed-cases-of-measles-mumps-and-rubella-in-england-and-wales-2012-to-2013 (Accessed 24 May 2017)."},{"key":"10.1016\/j.ajp.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/1567205012666150302154121","article-title":"Vanutide Cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer\u2019s disease: results from two phase 2 studies","volume":"12","author":"Arai","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ajp.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","article-title":"Evaluation of the safety and immunogenicity of synthetic A\u03b242 (AN1792) in patients with AD","volume":"64","author":"Bayer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2018.02.004_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/14712598.8.4.379","article-title":"Vaccines to combat smoking","volume":"8","author":"Bevins","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ajp.2018.02.004_bib0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.ajp.2018.02.004_bib0040","first-page":"18","article-title":"Psychobiology of vaccination effects: bidirectional relevance of depression","volume":"21","author":"Brogan","year":"2015","journal-title":"Altern. Ther. Health Med."},{"key":"10.1016\/j.ajp.2018.02.004_bib0045","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2011.12.127","article-title":"UK parents\u2019 decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis","volume":"30","author":"Brown","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ajp.2018.02.004_bib0050","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajp.2018.02.004_bib0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.285.9.1183","article-title":"Time trends in Autism and in MMR immunization coverage in California","volume":"285","author":"Dales","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajp.2018.02.004_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/shm\/10.2.291","article-title":"The rise and fall of pink disease","volume":"10","author":"Dally","year":"1997","journal-title":"Soc. Hist. Med."},{"key":"10.1016\/j.ajp.2018.02.004_bib0065","doi-asserted-by":"crossref","first-page":"c1127","DOI":"10.1136\/bmj.c1127","article-title":"Wakefield\u2019s autistic enterocolitis under the microscope","volume":"340","author":"Deer","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2018.02.004_bib0070","first-page":"751","article-title":"Vaccinations in psychiatry","volume":"51","author":"Dols","year":"2009","journal-title":"Tijd. voor Psychiatr."},{"key":"10.1016\/j.ajp.2018.02.004_bib0075","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1503\/cmaj.109-3179","article-title":"Lancet retracts 12-year-old article linking autism to MMR vaccines","volume":"182","author":"Eggertson","year":"2010","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ajp.2018.02.004_bib0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.2012.12060793","article-title":"Effect of a nicotine vaccine on nicotine binding to \u03b22*-nicotinic acetylcholine receptors in vivo in human tobacco smokers","volume":"170","author":"Esterlis","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2018.02.004_bib0085","first-page":"117","article-title":"Immunotherapy of 436 morphine addicts by therapeutic morphine vaccine in Kerman province (IR Iran)","volume":"2","author":"Farhangi","year":"2012","journal-title":"J. Vaccin Vaccin."},{"key":"10.1016\/j.ajp.2018.02.004_bib0090","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/S0264-410X(01)00097-4","article-title":"MMR and autism: further evidence against a causal association","volume":"19","author":"Farrington","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ajp.2018.02.004_bib0095","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4161\/hv.28183","article-title":"Vaccination against Alzheimer disease: an update on future strategies","volume":"10","author":"Fettelschoss","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ajp.2018.02.004_bib0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2018.02.004_bib0105","doi-asserted-by":"crossref","first-page":"c7452","DOI":"10.1136\/bmj.c7452","article-title":"Wakefield\u2019s article linking MMR vaccine and autism was fraudulent","volume":"342","author":"Godlee","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2018.02.004_bib0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/hv.22060","article-title":"Nicotine vaccines to treat tobacco dependence","volume":"9","author":"Goniewicz","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"issue":"7","key":"10.1016\/j.ajp.2018.02.004_bib0115","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2174\/1567205014666170117101537","article-title":"Long-term extensions of randomized vaccination trials of ACC-001 and QS-21 in mild to moderate Alzheimer\u2019s disease","volume":"14","author":"H\u00fcll","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ajp.2018.02.004_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1586\/14760584.3.1.11","article-title":"Therapeutic vaccines for substance dependence","volume":"3","author":"Haney","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ajp.2018.02.004_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2009.08.031","article-title":"Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans","volume":"67","author":"Haney","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2018.02.004_bib0130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"Hatsukami","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ajp.2018.02.004_bib0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ajp.2018.02.004_bib0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of A\u03b2 42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2018.02.004_bib0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1469-7610.2005.01425.x","article-title":"No effect of MMR withdrawal on the incidence of autism: a total population study","volume":"46","author":"Honda","year":"2005","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.ajp.2018.02.004_bib0150","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/add.12573","article-title":"Efficacy of the nicotine vaccine 3\u2032-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial","volume":"109","author":"Hoogsteder","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2018.02.004_bib0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0883073812447685","article-title":"Children with developmental disabilities in India: age of initial concern and referral for rehabilitation services, and reasons for delay in referral","volume":"28","author":"Jain","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1023\/A:1005443726670","article-title":"Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism","volume":"45","author":"Kawashima","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ajp.2018.02.004_bib0165","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.mp.4001165","article-title":"Neuropathology of infantile autism","volume":"7","author":"Kemper","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2018.02.004_bib0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.9758\/cpn.2016.14.4.396","article-title":"Recurrence of panic attacks after influenza vaccination: two case reports","volume":"14","author":"Kim","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ajp.2018.02.004_bib0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/2051013614537818","article-title":"Vaccines against drugs of abuse: where are we now?","volume":"2","author":"Kinsey","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.ajp.2018.02.004_bib0180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/088307380001500707","article-title":"Congenital Minamata disease: warnings from Japan\u2019s experience","volume":"15","author":"Kondo","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ajp.2018.02.004_bib0190","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ajp.2018.02.004_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2013.02.037","article-title":"DBH gene as predictor of response in a cocaine vaccine clinical trial","volume":"541","author":"Kosten","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ajp.2018.02.004_bib0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bcp.12115","article-title":"Vaccines against stimulants: cocaine and MA","volume":"77","author":"Kosten","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0205","first-page":"ntq015","article-title":"Nicotine vaccines: will smokers take a shot at quitting?","author":"Leader","year":"2010","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.ajp.2018.02.004_bib0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-8-36","article-title":"Immunotherapy for Alzheimer\u2019s disease: hoops and hurdles","volume":"8","author":"Lemere","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ajp.2018.02.004_bib0215","first-page":"8","article-title":"Temporal association of certain neuropsychiatric Disorders Following Vaccination of children and adolescents: a Pilot case\u2013control study","author":"Leslie","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ajp.2018.02.004_bib0220","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.112.3.604","article-title":"Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data","volume":"112","author":"Madsen","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajp.2018.02.004_bib0225","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2018.02.004_bib0230","series-title":"The Global Burden of Disease: 2004 Update","author":"Mathers","year":"2008"},{"key":"10.1016\/j.ajp.2018.02.004_bib0235","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","article-title":"A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity","volume":"35","author":"Maurer","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","article-title":"Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses","volume":"8","author":"Modabbernia","year":"2017","journal-title":"Mol. Autism"},{"key":"10.1016\/j.ajp.2018.02.004_bib0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1088469","article-title":"Immunotherapeutic approaches to Alzheimer\u2019s disease","volume":"302","author":"Monsonego","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ajp.2018.02.004_bib0250","volume":"vol. 8","year":"2015"},{"key":"10.1016\/j.ajp.2018.02.004_bib0255","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-\u03b2 peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajp.2018.02.004_bib0260","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","article-title":"A\u03b2 species removal after A\u03b242 immunization","volume":"65","author":"Nicoll","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YPG.0000000000000008","article-title":"\u03ba-Opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial","volume":"23","author":"Nielsen","year":"2013","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.ajp.2018.02.004_bib0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","article-title":"Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"16","author":"Novak","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2018.02.004_bib0280","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1441.027","article-title":"Substance abuse vaccines","volume":"1141","author":"Orson","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ajp.2018.02.004_bib0285","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.2004-0434","article-title":"Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data","volume":"114","author":"Parker","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajp.2018.02.004_bib0290","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3233\/JAD-150376","article-title":"Two phase 2 multiple ascending-dose studies of vanutide cridificar (ACC-001) and QS-21 adjuvant in mild-to-moderate Alzheimer\u2019s disease","volume":"51","author":"Pasquier","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ajp.2018.02.004_bib0295","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/B978-0-12-420118-7.00014-7","article-title":"New directions in nicotine vaccine design and use","volume":"69","author":"Pentel","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0300","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(02)11682-5","article-title":"Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study","volume":"360","author":"Pichichero","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2018.02.004_bib0305","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/596476","article-title":"Vaccines and autism: a tale of shifting hypotheses","volume":"48","author":"Plotkin","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ajp.2018.02.004_bib0310","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1080\/21645515.2016.1212785","article-title":"Biologics to treat substance use disorders: current status and new directions","volume":"12","author":"Pravetoni","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ajp.2018.02.004_bib0315","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid s s-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ajp.2018.02.004_bib0320","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neurobiolaging.2003.12.020","article-title":"Lessons from the AN 1792 Alzheimer vaccine: lest we forget","volume":"25","author":"Robinson","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ajp.2018.02.004_bib0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.2005.tb01779.x","article-title":"Incidence of autism spectrum disorders: changes over time and their meaning*","volume":"94","author":"Rutter","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ajp.2018.02.004_bib0330","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0197-4580(02)00124-0","article-title":"A safer vaccine for Alzheimer\u2019s disease?","volume":"23","author":"Sigurdsson","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ajp.2018.02.004_bib0335","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.324.7334.393","article-title":"Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study","volume":"324","author":"Taylor","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2018.02.004_bib0340","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ntr\/ntt003","article-title":"Niccine\u00ae, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial","volume":"15","author":"Tonstad","year":"2013","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.ajp.2018.02.004_bib0345","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"RETRACTED: ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2018.02.004_bib0350","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer\u2019s disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ajp.2018.02.004_bib0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt237","article-title":"Active immunotherapy options for Alzheimer\u2019s disease","volume":"6","author":"Winblad","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ajp.2018.02.004_bib0360","first-page":"151","article-title":"The epidemiology of autistic spectrum disorders: is the prevalence rising?","volume":"8","author":"Wing","year":"2002","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.ajp.2018.02.004_bib0365","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","article-title":"Immunotherapeutic approaches for Alzheimer\u2019s disease","volume":"85","author":"Wisniewski","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.ajp.2018.02.004_bib0370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuro.2014.06.007","article-title":"A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit\/hyperactivity disorder in the childhood","volume":"44","author":"Yoshimasu","year":"2014","journal-title":"Neurotoxicology"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201817304033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201817304033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:29:48Z","timestamp":1761755388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201817304033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":74,"alternative-id":["S1876201817304033"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2018.02.004","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of vaccines in psychiatry\u2014A narrative review","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}